Developing mitochondrial small molecule drugs for epilepsy, Parkinson's and other difficult to treat neurological diseases

Medication-Resistant Epilepsy Affects 1 Million Patients in the U.S.

That’s where Neuroene Therapeutics comes in.


Let's Talk 


sherine@neuroenetherapeutics.com

Additional Info

Expiration Date : 12/31/2025

Promo Code : MTCMember

Powered By GrowthZone

LEARN ABOUT MEMBERSHIP

LOG IN TO ACCESS
MEMBER TO MEMBER DISCOUNTS